D J Koehn Consulting Services Inc. - Medicare Mental Health Clinic in Fort Myers, FL

D J Koehn Consulting Services Inc. is a medicare enrolled mental health clinic (Behavior Analyst) in Fort Myers, Florida. The current practice location for D J Koehn Consulting Services Inc. is 8359 Beacon Blvd Ste 301, Fort Myers, Florida. For appointments, you can reach them via phone at (571) 309-7993. The mailing address for D J Koehn Consulting Services Inc. is Po Box 6552, Sheridan, Wyoming and phone number is (571) 309-7993.

D J Koehn Consulting Services Inc. is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1003329632. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (571) 309-7993.

Contact Information

D J Koehn Consulting Services Inc.
8359 Beacon Blvd Ste 301
Fort Myers
FL 33907-3059
(571) 309-7993
(800) 387-5701

Mental Health Clinic Profile

Full NameD J Koehn Consulting Services Inc.
SpecialityBehavior Analyst
Location8359 Beacon Blvd Ste 301, Fort Myers, Florida
Authorized Official Name and PositionDavid James Koehn (PRESIDENT)
Authorized Official Contact5713097993
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
D J Koehn Consulting Services Inc.
Po Box 6552
Sheridan
WY 82801-7100

Ph: (571) 309-7993
D J Koehn Consulting Services Inc.
8359 Beacon Blvd Ste 301
Fort Myers
FL 33907-3059

Ph: (571) 309-7993

NPI Details:

NPI Number1003329632
Provider Enumeration Date11/06/2017
Last Update Date11/06/2020
Certification Date11/06/2020

Medicare PECOS Information:

Medicare PECOS PAC ID5597024653
Medicare Enrollment IDO20180117002144

News Archive

Despite progress in malaria vaccine development, funding remains potential stumbling block

In this Guardian opinion piece, the newspaper's health editor, Sarah Boseley, responds to the positive results of a large-scale clinical trial of an experimental malaria vaccine reported on Tuesday and recaps other strides made against the disease in recent years, writing that "there is a way to go yet, with more results from the trial to come, and many uncertainties, including how much this vaccine will cost and who will be persuaded to pay."

Repligen files IND for Phase 1 study of RG2833 selective HDAC-3 inhibitor for Friedreich's ataxia

Repligen Corporation announced today that it has filed an Investigational New Drug Application (IND) with the Food and Drug Administration (FDA) for a Phase 1 study of RG2833, a selective histone deacetylase 3 (HDAC-3) inhibitor. This is a double-blind, single ascending dose, Phase 1 study in healthy volunteers to evaluate the pharmacokinetic and safety profile of RG2833 in up to 40 subjects.

Nevada AG files antitrust lawsuit against health care merger

The Associated Press/KLAS-TV in Las Vegas: "The Nevada attorney general's office has filed a federal antitrust lawsuit against a $3.1 billion health care merger it says would reduce competition for psychiatric care in Las Vegas. ... The lawsuit is aimed at a proposed merger between Universal Health Services Inc. and Psychiatric Solutions Inc."

UAlberta chemistry professor develops revolutionary neuroscience tools

UAlberta chemistry professor Robert Campbell is developing new ways to see and manipulate the activity of neurons in the brain, which could revolutionize the way we understand the organ that controls most of the activities of the body.

Read more Medical News

› Verified 6 days ago

Medical Identifiers

Medical identifiers for D J Koehn Consulting Services Inc. such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003329632NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
103K00000XBehavior Analyst (* (Not Available))Primary
103TC0700XPsychologist - Clinical (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. D J Koehn Consulting Services Inc. acts as a billing entity for following providers:
Provider NameDavid J Koehn
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1700217429
PECOS PAC ID: 4385866813
Enrollment ID: I20141117001097

News Archive

Despite progress in malaria vaccine development, funding remains potential stumbling block

In this Guardian opinion piece, the newspaper's health editor, Sarah Boseley, responds to the positive results of a large-scale clinical trial of an experimental malaria vaccine reported on Tuesday and recaps other strides made against the disease in recent years, writing that "there is a way to go yet, with more results from the trial to come, and many uncertainties, including how much this vaccine will cost and who will be persuaded to pay."

Repligen files IND for Phase 1 study of RG2833 selective HDAC-3 inhibitor for Friedreich's ataxia

Repligen Corporation announced today that it has filed an Investigational New Drug Application (IND) with the Food and Drug Administration (FDA) for a Phase 1 study of RG2833, a selective histone deacetylase 3 (HDAC-3) inhibitor. This is a double-blind, single ascending dose, Phase 1 study in healthy volunteers to evaluate the pharmacokinetic and safety profile of RG2833 in up to 40 subjects.

Nevada AG files antitrust lawsuit against health care merger

The Associated Press/KLAS-TV in Las Vegas: "The Nevada attorney general's office has filed a federal antitrust lawsuit against a $3.1 billion health care merger it says would reduce competition for psychiatric care in Las Vegas. ... The lawsuit is aimed at a proposed merger between Universal Health Services Inc. and Psychiatric Solutions Inc."

UAlberta chemistry professor develops revolutionary neuroscience tools

UAlberta chemistry professor Robert Campbell is developing new ways to see and manipulate the activity of neurons in the brain, which could revolutionize the way we understand the organ that controls most of the activities of the body.

Read more Medical News

› Verified 6 days ago

Provider NameNelson Lloyd Hadler
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1952748980
PECOS PAC ID: 6103253976
Enrollment ID: I20200218000949

News Archive

Despite progress in malaria vaccine development, funding remains potential stumbling block

In this Guardian opinion piece, the newspaper's health editor, Sarah Boseley, responds to the positive results of a large-scale clinical trial of an experimental malaria vaccine reported on Tuesday and recaps other strides made against the disease in recent years, writing that "there is a way to go yet, with more results from the trial to come, and many uncertainties, including how much this vaccine will cost and who will be persuaded to pay."

Repligen files IND for Phase 1 study of RG2833 selective HDAC-3 inhibitor for Friedreich's ataxia

Repligen Corporation announced today that it has filed an Investigational New Drug Application (IND) with the Food and Drug Administration (FDA) for a Phase 1 study of RG2833, a selective histone deacetylase 3 (HDAC-3) inhibitor. This is a double-blind, single ascending dose, Phase 1 study in healthy volunteers to evaluate the pharmacokinetic and safety profile of RG2833 in up to 40 subjects.

Nevada AG files antitrust lawsuit against health care merger

The Associated Press/KLAS-TV in Las Vegas: "The Nevada attorney general's office has filed a federal antitrust lawsuit against a $3.1 billion health care merger it says would reduce competition for psychiatric care in Las Vegas. ... The lawsuit is aimed at a proposed merger between Universal Health Services Inc. and Psychiatric Solutions Inc."

UAlberta chemistry professor develops revolutionary neuroscience tools

UAlberta chemistry professor Robert Campbell is developing new ways to see and manipulate the activity of neurons in the brain, which could revolutionize the way we understand the organ that controls most of the activities of the body.

Read more Medical News

› Verified 6 days ago

News Archive

Despite progress in malaria vaccine development, funding remains potential stumbling block

In this Guardian opinion piece, the newspaper's health editor, Sarah Boseley, responds to the positive results of a large-scale clinical trial of an experimental malaria vaccine reported on Tuesday and recaps other strides made against the disease in recent years, writing that "there is a way to go yet, with more results from the trial to come, and many uncertainties, including how much this vaccine will cost and who will be persuaded to pay."

Repligen files IND for Phase 1 study of RG2833 selective HDAC-3 inhibitor for Friedreich's ataxia

Repligen Corporation announced today that it has filed an Investigational New Drug Application (IND) with the Food and Drug Administration (FDA) for a Phase 1 study of RG2833, a selective histone deacetylase 3 (HDAC-3) inhibitor. This is a double-blind, single ascending dose, Phase 1 study in healthy volunteers to evaluate the pharmacokinetic and safety profile of RG2833 in up to 40 subjects.

Nevada AG files antitrust lawsuit against health care merger

The Associated Press/KLAS-TV in Las Vegas: "The Nevada attorney general's office has filed a federal antitrust lawsuit against a $3.1 billion health care merger it says would reduce competition for psychiatric care in Las Vegas. ... The lawsuit is aimed at a proposed merger between Universal Health Services Inc. and Psychiatric Solutions Inc."

UAlberta chemistry professor develops revolutionary neuroscience tools

UAlberta chemistry professor Robert Campbell is developing new ways to see and manipulate the activity of neurons in the brain, which could revolutionize the way we understand the organ that controls most of the activities of the body.

Read more News

› Verified 6 days ago

Behavior Analyst in Fort Myers, FL

Fort Myers Psychology, Pa
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 12791 World Plaza Ln Bldg 89, Fort Myers, FL 33907
Phone: 239-829-5494    Fax: 239-645-4777
Neuropsychiatric Research Center Of Southwest Florida Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 14271 Metropolis Ave, Suite A, Fort Myers, FL 33912
Phone: 239-939-7777    Fax: 239-936-0036
Hope Community Wellness Center Corp
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 6238 Presidential Ct # Crt 7/8, Fort Myers, FL 33919
Phone: 863-233-9190    
Health Planning Council Of Southwest Florida, Inc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 8961 Daniels Center Dr Ste 401, Fort Myers, FL 33912
Phone: 239-433-6700    
Nest Academy & Therapy Center Inc.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 4755 Summerlin Rd Ste 4, Fort Myers, FL 33919
Phone: 786-382-5779    
Gables Rehab Center Corp
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3049 Cleveland Ave Ste 145, Fort Myers, FL 33901
Phone: 786-641-1312    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.